|
You are here : Home/ AIDS Zone/ HIV is a RetrovirusHow HIV Causes AIDS - HIV is a Retrovirus
AIDS Zone HIV belongs to a class of viruses called retroviruses. Retroviruses are ribonucleic acid (RNA) viruses, and in order to replicate they must make a deoxyribonucleic acid (DNA) copy of their RNA. It is the DNA genes that allow the virus to replicate.What is AIDS Role of Blood in AIDS How HIV is transmitted Early symptoms of HIV HIV infection diagnosis HIV infection treatment Preventions of HIV infection Researches going on AIDS How HIV Causes AIDS --Overview --Scope --Retrovirus Early Events in HIV Infection Course of HIV Infection HIV and Lymph Nodes Role of CD8+ T Cells Replication and Mutation Immune System Cell Loss Immune Activation in HIV Laboratory Diagnosis for AIDS AIDS drugs in use AIDS drugs in development AIDS Statistics Epidemic Introduction Actions for HIV prevention Intensifying Prevention AIDS Nutrition for people with HIV Organise AIDS Awareness AIDS Factsheet Glossary Open your heart - AIDS AIDS Count AIDS NGOs Directory Youth and AIDS See Also Manage your Health Records Take Clinical Test Reports My Diabetes Test History Write Blogs on Safe - Blood Submit Reseach Papers Start Clinical Discussion Go News Zone
Like all viruses, HIV can replicate only inside cells, commandeering the cell's machinery to reproduce. However, only HIV and other retroviruses, once inside a cell, use an enzyme called reverse transcriptase to convert their RNA into DNA, which can be incorporated into the host cell's genes. ![]() Infection typically begins when an HIV particle, which contains two copies of the HIV RNA, encounters a cell with a surface molecule called cluster designation 4 (CD4). Cells carrying this molecule are known as CD4 positive (CD4+) cells. One or more of the virus's gp120 molecules binds tightly to CD4 molecule(s) on the cell's surface. The binding of gp120 to CD4 results in a conformational change in the gp120 molecule allowing it to bind to a second molecule on the cell surface known as a coreceptor. The envelope of the virus and the cell membrane then fuse, leading to entry of the virus into the cell. The gp41 of the envelope is critical to the fusion process. Drugs that block either the binding or the fusion process are being developed and tested in clinical trials. Studies have identified multiple coreceptors for different types of HIV strains; these coreceptors are promising targets for new anti-HIV drugs, some of which are now being tested in pre-clinical and clinical studies. In the early stage of HIV disease, most people harbor viruses that use, in addition to CD4, a receptor called CCR5 to enter their target cells. With disease progression, the spectrum of coreceptor usage expands in approximately 50 percent of patients to include other receptors, notably a molecule called CXCR4. Virus that utilizes CCR5 is called R5 HIV and virus that utilizes CXCR4 is called X4 HIV. Although CD4+ T cells appear to be the main targets of HIV, other immune system cells with and without CD4 molecules on their surfaces are infected as well. Among these are long-lived cells called monocytes and macrophages, which apparently can harbor large quantities of the virus without being killed, thus acting as reservoirs of HIV. CD4+ T cells also serve as important reservoirs of HIV: a small proportion of these cells harbor HIV in a stable, inactive form. Normal immune processes may activate these cells, resulting in the production of new HIV virions Cell-to-cell spread of HIV also can occur through the CD4-mediated fusion of an infected cell with an uninfected cell. Reverse transcription In the cytoplasm of the cell, HIV reverse transcriptase converts viral RNA into DNA, the nucleic acid form in which the cell carries its genes. Nine of the 15 antiviral drugs approved in the US for the treatment of people with HIV infection -- AZT, ddC, ddI, d4T, 3TC, nevirapine, delavirdine, abacavir and efavirenz -- work by interfering with this stage of the viral life cycle. Integration The newly made HIV DNA moves to the cell's nucleus, where it is spliced into the host's DNA with the help of HIV integrase. HIV DNA that enters the DNA of the cell is called a "provirus." Integrase is an important target for the development of new drugs Transcription For a provirus to produce new viruses, RNA copies must be made that can be read by the host cell's protein-making machinery. These copies are called messenger RNA (mRNA), and production of mRNA is called transcription, a process that involves the host cell's own enzymes. Viral genes in concert with the cellular machinery control this process: the tat gene, for example, encodes a protein that accelerates transcription. Genomic RNA is also transcribed for later incorporation in the budding virion. Cytokines, proteins involved in the normal regulation of the immune response, also may regulate transcription. Molecules such as tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, secreted in elevated levels by the cells of HIV-infected people, may help to activate HIV proviruses. Other infections, by organisms such as Mycobacterium tuberculosis, may also enhance transcription by inducing the secretion of cytokines. Translation After HIV mRNA is processed in the cell's nucleus, it is transported to the cytoplasm. HIV proteins are critical to this process: for example, a protein encoded by the rev gene allows mRNA encoding HIV structural proteins to be transferred from the nucleus to the cytoplasm. Without the rev protein, structural proteins are not made. In the cytoplasm, the virus co-opts the cell's protein-making machinery - including structures called ribosomes - to make long chains of viral proteins and enzymes, using HIV mRNA as a template. This process is called translation. Assembly and budding Newly made HIV core proteins, enzymes and genomic RNA gather just inside the cell's membrane, while the viral envelope proteins aggregate within the membrane. An immature viral particle forms and buds off from the cell, acquiring an envelope that includes both cellular and HIV proteins from the cell membrane. During this part of the viral life cycle, the core of the virus is immature and the virus is not yet infectious. The long chains of proteins and enzymes that make up the immature viral core are now cleaved into smaller pieces by a viral enzyme called protease. This step results in infectious viral particles. |
Related pages The Carcinogens Glossary aids Antireteroviral Theraphy The role of blood in aids SAFETY IN THE LABORATORY |
|||
|
|||||
|
Events | About us | Link to us | Contact us | Associates | Services | Fund-rising options | Feedback | Privacy policy | Disclaimer | Report Bugs © 2007 bloodindex |
|||||